Millennium Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79M Buy
1,051,506
+958,244
+1,027% +$75.6M 0.03% 563
2025
Q4
$7.38M Sell
93,262
-686,308
-88% -$51.7M ﹤0.01% 2585
2025
Q3
$51M Sell
779,570
-1,869,957
-71% -$91.3M 0.02% 859
2025
Q2
$105M Buy
2,649,527
+2,014,157
+317% +$65.9M 0.05% 371
2025
Q1
$19.2M Sell
635,370
-138,845
-18% -$4.55M 0.01% 1560
2024
Q4
$27.1M Buy
774,215
+343,492
+80% +$12.8M 0.01% 1270
2024
Q3
$17.3M Buy
430,723
+302,508
+236% +$14.1M 0.01% 1680
2024
Q2
$6.11M Sell
128,215
-454,964
-78% -$18.7M ﹤0.01% 2535
2024
Q1
$25.3M Sell
583,179
-307,146
-34% -$14.6M 0.01% 1357
2023
Q4
$45M Buy
890,325
+453,202
+104% +$21.7M 0.02% 869
2023
Q3
$19.8M Buy
437,123
+18,210
+4% +$751K 0.01% 1449
2023
Q2
$17.2M Buy
418,913
+373,550
+823% +$14.4M 0.01% 1526
2023
Q1
$1.62M Sell
45,363
-70,143
-61% -$2.63M ﹤0.01% 3635
2022
Q4
$4.36M Buy
115,506
+96,577
+510% +$4.06M ﹤0.01% 2932
2022
Q3
$837K Sell
18,929
-301,686
-94% -$12.7M ﹤0.01% 4486
2022
Q2
$11.9M Buy
320,615
+129,424
+68% +$4.88M 0.01% 1833
2022
Q1
$7.08M Sell
191,191
-1,431,947
-88% -$46.9M ﹤0.01% 2557
2021
Q4
$49.4M Buy
1,623,138
+1,340,284
+474% +$42.2M 0.03% 729
2021
Q3
$9.49M Sell
282,854
-512,988
-64% -$19.3M 0.01% 2126
2021
Q2
$31.7M Buy
795,842
+164,578
+26% +$6.45M 0.02% 860
2021
Q1
$28.4M Buy
631,264
+100,675
+19% +$5.61M 0.02% 831
2020
Q4
$30M Buy
530,589
+421,632
+387% +$21M 0.02% 775
2020
Q3
$5.17K Buy
108,957
+95,588
+715% +$5.31M 0.01% 1809
2020
Q2
$788K Sell
13,369
-58,223
-81% -$3.24M ﹤0.01% 3133
2020
Q1
$3.38M Buy
71,592
+61,528
+611% +$3.43M 0.01% 1635
2019
Q4
$608K Sell
10,064
-45,141
-82% -$2.69M ﹤0.01% 3264
2019
Q3
$3.31M Sell
55,205
-135,739
-71% -$8.85M 0.01% 2106
2019
Q2
$12.3M Buy
190,944
+25,905
+16% +$1.83M 0.02% 1104
2019
Q1
$13.4M Buy
165,039
+81,561
+98% +$5.26M 0.02% 1066
2018
Q4
$4.51M Sell
83,478
-44,849
-35% -$2.29M 0.01% 1660
2018
Q3
$6.62M Sell
128,327
-53,607
-29% -$2.52M 0.01% 1605
2018
Q2
$7.58M Sell
181,934
-90,903
-33% -$4.03M 0.01% 1509
2018
Q1
$12M Buy
272,837
+76,920
+39% +$3.91M 0.02% 1215
2017
Q4
$9.86M Buy
195,917
+2,874
+1% +$158K 0.01% 1331
2017
Q3
$9.79M Buy
193,043
+96,324
+100% +$5.05M 0.01% 1262
2017
Q2
$4.92M Sell
96,719
-152,610
-61% -$7.11M 0.01% 1521
2017
Q1
$10M Buy
249,329
+244,954
+5,599% +$11M 0.02% 1021
2016
Q4
$209K Sell
4,375
-1,601,931
-100% -$63.4M ﹤0.01% 3066
2016
Q3
$58.9M Buy
+1,606,306
New +$50.3M 0.1% 217
2016
Q2
Sell
-1,078,089
Closed -$43.7M 3359
2016
Q1
$43.7M Buy
+1,078,089
New +$43.8M 0.11% 211
2015
Q4
Sell
-180,814
Closed -$7.31M 3586
2015
Q3
$7.31M Sell
180,814
-187,242
-51% -$9.69M 0.01% 1117
2015
Q2
$21.2M Buy
368,056
+361,256
+5,313% +$23M 0.04% 600
2015
Q1
$433K Buy
+6,800
New +$461K ﹤0.01% 2828
2014
Q3
Sell
-198,138
Closed -$6.83M 3838
2014
Q2
$6.83M Sell
198,138
-10,243
-5% -$323K 0.02% 1018
2014
Q1
$9M Buy
208,381
+168,381
+421% +$8.16M 0.03% 870
2013
Q4
$1.59M Sell
40,000
-220,133
-85% -$7.84M 0.01% 1980
2013
Q3
$9.77M Sell
260,133
-554,185
-68% -$16.6M 0.03% 692
2013
Q2
$21.9M Buy
+814,318
New +$17.3M 0.07% 269

Other funds holding IONS

Millennium Management's IONS Position: Q1 2026 in Review

Millennium Management increased its Ionis Pharmaceuticals (IONS) stake by 1,027% in Q1 2026, buying an estimated $75.6M and bringing the position to 1,051,506 shares worth $79M. The position accounts for 0.03% of the portfolio, ranked #563.

Millennium Management first reported a position in IONS in Q2 2013 and has held it in 48 quarters since. The position peaked at $105M in Q2 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Millennium Management held 1,051,506 shares of Ionis Pharmaceuticals worth $79M as of Q1 2026.
  • Millennium Management bought 958,244 Ionis Pharmaceuticals shares in Q1 2026, an estimated $75.6M.
  • Ionis Pharmaceuticals made up 0.03% of Millennium Management's portfolio in Q1 2026, its #563 holding.
  • Millennium Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
  • Millennium Management's Ionis Pharmaceuticals position peaked at $105M in Q2 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.